Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 36 Records) |
| Query Trace: Philadelphia Chromosome and JAK2[original query] |
|---|
| JAK2 (V617F) mutation is not associated with thrombosis in Behcet syndrome. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2012 Jul 18 (4): 421-6. Ar M Cem, Hatemi Gülen, Ekizo?lu Seda, Bilgen Hülya, Saçli Sevgi, Buyru A Nur, Soysal Teoman, Ülkü Birsen, Yazici Has |
| Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F. Archives of pathology & laboratory medicine 2014 Sep 138 (9): 1203-9. Vytrva Nataliya, Stacher Elvira, Regitnig Peter, Zinke-Cerwenka Wilma, Hojas Sabine, Hubmann Eva, Porwit Anna, Bjorkholm Magnus, Hoefler Gerald, Beham-Schmid Christi |
| The mutation profile of JAK2 and CALR in Chinese Han patients with Philadelphia chromosome-negative myeloproliferative neoplasms. Journal of hematology & oncology 2014 7 48. Wu Zhiyuan, Zhang Xinju, Xu Xiao, Chen Yuming, Hu Tingting, Kang Zhihua, Li Shibao, Wang Hua, Liu Weiwei, Ma Xiaochao, Guan Mi |
| JAK2 V617F detected in two B-cell chronic lymphocytic leukemia patients without coexisting Philadelphia chromosome-negative myeloproliferative neoplasms: A report of two cases. Oncology letters 2014 Aug 8 (2): 841-844. Yang Yi-Ning, Qin You-Wen, Wang Ch |
| Evaluation of clinical and laboratory findings with JAK2 V617F mutation as an independent variable in essential thrombocytosis. Molecular biology reports 2014 Oct 41 (10): 6737-42. Cetin Güven, Ozkan Tuba, Turgut Seda, Ali Cikrikcioglu M, Cem Ar M, Ayer Mesut, Unlu Ayhan, Celik Sevda Rabia, Sekin Yahya, Karatoprak Cuma |
| Association between thromboembolic events and the JAK2 V617F mutation in myeloproliferative neoplasms. The Kurume medical journal 2014 60 (3-4): 89-97. Takata Yuka, Seki Ritsuko, Kanajii Taisuke, Nohara Masayuki, Koteda Satoko, Kawaguchi Kuniki, Nomura Kei, Nakamura Takayuki, Morishige Satoshi, Oku Eijirou, Osaki Koichi, Hashiguchi Emichitoshi, Mouri Fumihiko, Yoshimoto Koji, Nagafuji Koji, Okamura Takas |
| Frequency of JAK2 V617F mutation in patients with Philadelphia positive Chronic Myeloid Leukemia in Pakistan. Pakistan journal of medical sciences 2014 Jan 30 (1): 185-8. Tabassum Najia, Saboor Mohammed, Ghani Rubina, Moinuddin Moinudd |
| Analysis of JAK2V617F mutation in Jordanian patients with myeloproliferative neoplasms. Hematology/oncology and stem cell therapy 2015 Aug . Jaradat Saied A, Khasawneh Rawan, Kamal Nazmi, Matalka Ismail, Al-Bishtawi Mohammed, Al-Sweedan Suleiman, Ayesh Mahmoud |
| Adults with Philadelphia chromosome-like acute lymphoblastic leukemia frequently have IGH-CRLF2 and JAK2 mutations, persistence of minimal residual disease and poor prognosis. Haematologica 2017 Jan 102 (1): 130-138. Herold Tobias, Schneider Stephanie, Metzeler Klaus H, Neumann Martin, Hartmann Luise, Roberts Kathryn G, Konstandin Nikola P, Greif Philipp A, Bräundl Kathrin, Ksienzyk Bianka, Huk Natalia, Schneider Irene, Zellmeier Evelyn, Jurinovic Vindi, Mansmann Ulrich, Hiddemann Wolfgang, Mullighan Charles G, Bohlander Stefan K, Spiekermann Karsten, Hoelzer Dieter, Brüggemann Monika, Baldus Claudia D, Dreyling Martin, Gökbuget Nico |
| Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms. Blood 2016 Jun . Hinds David A, Barnholt Kimberly E, Mesa Ruben A, Kiefer Amy K, Do Chuong B, Eriksson Nicholas, Mountain Joanna L, Francke Uta, Tung Joyce Y, Nguyen Huong Marie, Zhang Haiyu, Gojenola Linda, Zehnder James L, Gotlib Jas |
| Homozygous calreticulin mutations in patients with myelofibrosis lead to acquired myeloperoxidase deficiency. Blood 2016 Mar . Theocharides Alexandre P A, Lundberg Pontus, Lakkaraju Asvin K K, Lysenko Veronika, Myburgh Renier, Aguzzi Adriano, Skoda Radek C, Manz Markus |
| Determination of prognosis of Philadelphia chromosome-negative myeloproliferative neoplasms with a simple clinical examination: Retrospective analysis of 71 patients in a single institution. Molecular and clinical oncology 2016 Jan 4 (1): 51-57. Ito Shinichi, Tsutsumi Yutaka, Ohigashi Hiroyuki, Shiratori Souichi, Teshima Takano |
| Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults. Blood 2016 Dec . Jain Nitin, Roberts Kathryn G, Jabbour Elias, Patel Keyur, Eterovic Agda Karina, Chen Ken, Zweidler-McKay Patrick, Lu Xinyan, Fawcett Gloria, Wang Sa A, Konoplev Sergej, Harvey Richard C, Chen I-Ming, Payne-Turner Debbie, Valentine Marcus, Thomas Deborah, Garcia-Manero Guillermo, Ravandi Farhad, Cortes Jorge, Kornblau Steven, O'Brien Susan, Pierce Sherry, Jorgensen Jeffrey, Shaw Kenna R Mills, Willman Cheryl L, Mullighan Charles G, Kantarjian Hagop, Konopleva Mari |
| JAK2, MPL, and CALR mutations in Chinese Han patients with essential thrombocythemia. Hematology (Amsterdam, Netherlands) 2017 Apr 22 (3): 145-148. Wang Jing, Zhang Biao, Chen Bing, Zhou Rong-Fu, Zhang Qi-Guo, Li Juan, Yang Yong-Gong, Zhou Min, Shao Xiao-Yan, Xu Yong, Xu Xi-Hui, Ouyang Jian, Xu Jingyan, Ye Qi |
| Polycythemia vera: from new, modified diagnostic criteria to new therapeutic approaches. Clinical advances in hematology & oncology : H&O 2017 9 15 (9): 700-707. Maffioli Margherita, Mora Barbara, Passamonti Frances |
| Calreticulin Mutations in Bulgarian MPN Patients. Pathology oncology research : POR 2017 Apr . Pavlov Ivan, Hadjiev Evgueniy, Alaikov Tzvetan, Spassova Sylva, Stoimenov Angel, Naumova Elissaveta, Shivarov Velizar, Ivanova Mile |
| Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the Children's Oncology Group. Blood 2018 Jul . Roberts Kathryn G, Reshmi Shalini C, Harvey Richard C, Chen I-Ming, Patel Kinnari, Stonerock Eileen, Jenkins Heather, Dai Yunfeng, Valentine Marc, Gu Zhaohui, Zhao Yaqi, Zhang Jinghui, Payne-Turner Debbie, Devidas Meenakshi, Heerema Nyla A, Carroll Andrew J, Raetz Elizabeth A, Borowitz Michael J, Wood Brent L, Mattano Leonard A, Maloney Kelly W, Carroll William L, Loh Mignon L, Willman Cheryl L, Gastier-Foster Julie M, Mullighan Charles G, Hunger Stephen |
| The Role of Caspase Genes Polymorphisms in Genetic Susceptibility to Philadelphia-Negative Myeloproliferative Neoplasms in a Portuguese Population. Pathology oncology research : POR 2018 Mar . Azevedo Ana P, Silva Susana N, Reichert Alice, Lima Fernando, Júnior Esmeraldina, Rueff Jo |
| Effect of CALR and JAK2 mutations on the clinical and hematological phenotypes of the disease in patients with myelofibrosis - long-term experience from a single center. Neoplasma 2018 65 (2): 296-303. Palova M, Szotkowski T, Hlusi A, Indrak K, Navratilova J, Divoka M, Papajik |
| Mutational subtypes of JAK2 and CALR correlate with different clinical features in Japanese patients with myeloproliferative neoplasms. International journal of hematology 2018 Feb . Misawa Kyohei, Yasuda Hajime, Araki Marito, Ochiai Tomonori, Morishita Soji, Shirane Shuichi, Edahiro Yoko, Gotoh Akihiko, Ohsaka Akimichi, Komatsu Nor |
| Effects of polymorphic DNA genes involved in BER and caspase pathways on the clinical outcome of myeloproliferative neoplasms under treatment with hydroxyurea. Molecular medicine reports 2018 Oct . Azevedo Ana P, Silva Susana N, Reichert Alice, Lima Fernando, Júnior Esmeraldina, Rueff Jo |
| Influence of Blood Count, Cardiovascular Risks, Inherited Thrombophilia, and JAK2 V617F Burden Allele on Type of Thrombosis in Patients With Philadelphia Chromosome Negative Myeloproliferative Neoplasms. Clinical lymphoma, myeloma & leukemia 2018 10 19 (1): 53-63. Horvat Ivana, Boban Ana, Zadro Renata, Antolic Margareta Radic, Serventi-Seiwerth Ranka, Roncevic Pavle, Radman Ivo, Sertic Dubravka, Vodanovic Marijo, Pulanic Drazen, Basic-Kinda Sandra, Durakovic Nadira, Zupancic-Salek Silva, Vrhovac Radovan, Aurer Igor, Nemet Damir, Labar Bor |
| Analysis of the reannealing- instead of melting-curve in the detection of JAK2 V617F mutation by HRM method. Journal of blood medicine 2019 8 10 235-241. Moradabadi Alireza, Fatemi Ahmad, Noroozi-Aghideh A |
| Development of a high resolution melting analysis assay for rapid identification of JAK2 V617F missense mutation and its validation. Experimental hematology & oncology 2019 6 8 10. Moradabadi Alireza, Farsinejad Alireza, Khansarinejad Behzad, Fatemi Aha |
| Genetic polymorphisms and expression of NLRP3 inflammasome-related genes are associated with Philadelphia chromosome-negative myeloproliferative neoplasms. Human immunology 2020 9 81 (10-11): 606-613. Zhou Ying, Yan Shuxin, Liu Na, He Na, Zhang Amin, Meng Sibo, Ji Chunyan, Ma Daoxin, Ye Jingji |
| Hierarchical distribution of somatic variants in newly diagnosed chronic myeloid leukaemia at diagnosis and early follow-up. British journal of haematology 2021 Jul . Romzova Marianna, Smitalova Dagmar, Hynst Jakub, Tom Nikola, Loja Tomas, Herudkova Zdenka, Jurcek Tomas, Stejskal Lukas, Zackova Daniela, Mayer Jiri, Racil Zdenek, Culen Mart |
| Is Allogeneic Transplantation an Option in Patients Affected by Concurrent Myelofibrosis and Chronic Myeloid Leukemia (CML)? Mediterranean journal of hematology and infectious diseases 2021 11 13 (1): e2021062. Sora Federica, Chiusolo Patrizia, Autore Francesco, Giammarco Sabrina, Laurenti Luca, Innocenti Idanna, Metafuni Elisabetta, Galli Eugenio, Bacigalupo Andrea, Sica Simo |
| TET2, DNMT3A, IDH1, and JAK2 Mutation in Myeloproliferative Neoplasms in southern Iran. International journal of organ transplantation medicine 2022 5 12 (3): 12-20. Abedi E, Ramzi M, Karimi M, Yaghobi R, Mohammadi H, Bayat E, Moghadam M, Farokhian F, Dehghani M, Golafshan H A, Haghpanah |
| Prognostic relevance of surface expression of cytokine receptor-like factor 2 in pediatric B-lineage acute lymphoblastic leukemia. American journal of cancer research 2023 7 13 (6): 2452-2470. Jay Singh, Mercilena Benjamin, Avanish Kumar Pandey, Sarita Kumari, Mohammad Shadab Ali, Jayanth Kumar Palanichamy, Sameer Bakhshi, Amitabh Singh, Deepam Pushpam, Akash Kumar, Rachna Seth, Inder Singh, Pranay Tanwar, Amar Ranjan Singh, Gunjan Sharma, Mohit Arora, Anita Chop |
| Allelic burden of Janus kinase 2 in a 6-month course of therapy for myeloproliferative neoplasms. Molecular biology reports 2023 5 . It?r ?irino?lu Demiriz, Mehmet Hanifi Kazanci, Esra Menfaatli, Davoud Jafari-Gharabaghlou, Nosratollah Zargha |
- Page last reviewed:Oct 1, 2023
- Page last updated:Nov 17, 2023
- Content source: